|
1-deoxy-1-methoxycarbamido-beta-D-glucopyranose
|
DB03657 |
|
|
P113D
|
DB04987 |
[P113D is a novel 12 amino-acid antimicrobial peptide drug derived from histatins, which are compounds found naturally in human saliva. It is being pursued as a potential treatment for cystic fibrosis by Demegen, Inc.] |
|
ZYC300
|
DB04986 |
[ZYC300 is a plasmid DNA of CYP1B1 encapsulated in biodegradable poly-DL-lactide-coglycolide microparticles. It is designed as a vaccine, intended to increase immune system sensitivity to CYP1B1, an enzyme highly prevalent in tumor cells.] |
|
EM-1745
|
DB02323 |
|
|
S,S-Propylthiocysteine
|
DB03654 |
|
|
5-Iodo-2'-Deoxyuridine-5'-Monophosphate
|
DB02324 |
|
|
Tigapotide
|
DB04985 |
[Tigapotide is a synthetic 15-mer peptide that is derived from the natural sequence of amino acids of the prostate secretory protein (PSP94), one of three predominant proteins found in human seminal fluid.] |
|
beta-D-Galactopyranuronic acid
|
DB03652 |
|
|
5-(3-Amino-4,4-Dihyroxy-Butylsulfanylmethyl)-Tetrahydro-Furan-2,3,4-Triol
|
DB02321 |
|
|
Heparin Disaccharide I-S
|
DB02322 |
|
|
5-{[Ethyl(Methyl)Amino]Methyl}-2-Methyl-5,6-Dihydropyrimidin-4-Amine
|
DB03653 |
|
|
Denufosol
|
DB04983 |
[Denufosol was an inhaled drug used for the treatment of cystic fibrosis (CF), showing various improvements in lung function during a phase III clinical trial. A new drug application (NDA) was filed with the FDA in 2011, however, the second phase III clinical trial showed a lack of improvement in lung function for cystic fibrosis patients taking denufosol. The drug was also evaluated in the treatment of retinal detachment and other diseases of the retina. Denufosol has not gained FDA approval, and clinical trials with this drug have ceased since 2011.] |
|
Talampanel
|
DB04982 |
[Talampanel is a substance that is being studied in the treatment of brain tumors and other brain disorders, such as epilepsy and Parkinson disease. It is a type of AMPA receptor antagonist.] |
|
(3e)-3-[(4-Hydroxyphenyl)Imino]-1h-Indol-2(3h)-One
|
DB03650 |
|
|
Picric acid
|
DB03651 |
[Used as antiseptic, astringent, and stimulant for epitheliazation.] |
|
N-beta-D-glucopyranosylacetamide
|
DB02320 |
|
|
CG7870
|
DB04981 |
[CG7870 is an oncolytic virus therapy for prostate cancer. It is a replication-selective, prostate-specific antigen-targeted oncolytic adenovirus, for the treatment of hormone-refractory, metastatic prostate cancer.] |
|
2,5-Dimethylpyrimidin-4-Amine
|
DB02372 |
|
|
Adenosine monotungstate
|
DB02373 |
|
|
Nz-(1-Carboxyethyl)-Lysine
|
DB02370 |
|
